HC quashes prosecution against pharma company as its "substandard" drug sample expires before re-analysis
Jammu, Sept. 25 -- The High Court of J&K and Ladakh has quashed criminal proceedings against Maxmed Life Sciences Pvt. Ltd. and its director in a case concerning a drug sample declared "not of standard quality", holding that the company had been deprived of its statutory right to have the disputed sample re-analysed.
Justice Wasim Sadiq Nargal, in a judgment allowed a petition filed by Maxmed Life Sciences Pvt Ltd of Uttarakhand and its director, Sanjeev Wasan. The bench quashed the complaint and all consequential proceedings against the petitioners.
The case arose from a sample of the drug "Amzone", Batch No. MLI-386, manufactured by the company in December 2013.
The sample was lifted on January 16, 2014, from the premises of Chest Di...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.